Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Maitland, FL
mi
from
Maitland, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Maitland, FL
mi
from
Maitland, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Atlanta, GA
mi
from
Atlanta, GA
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Atlanta, GA
mi
from
Atlanta, GA
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Minneapolis, MN
mi
from
Minneapolis, MN
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Greenville, SC
mi
from
Greenville, SC
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Greenville, SC
mi
from
Greenville, SC
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Connecticut Children's Hospital Medical Center
mi
from
Hartford, CT
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Hospital Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated:  12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Multicenter Non-Therapeutic Study of Infliximab for Severe Refractory Colitis in Hospitalized Children
Status: Enrolling
Updated: 12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated:  12/31/1969
Endoscopy Center of Connecticut, LLC
mi
from
Guilford, CT
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated: 12/31/1969
Endoscopy Center of Connecticut, LLC
mi
from
Guilford, CT
Click here to add this to my saved trials
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated:  12/31/1969
Endoscopy Center of Connecticut, LLC
mi
from
Hamden, CT
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated: 12/31/1969
Endoscopy Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated:  12/31/1969
New Haven Clinical Research Unit
mi
from
New Haven, CT
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated: 12/31/1969
New Haven Clinical Research Unit
mi
from
New Haven, CT
Click here to add this to my saved trials
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis
PHASE 1B, OPEN LABEL STUDY TO CHARACTERIZE THE DISTRIBUTION OF A SINGLE INTRAVENOUS DOSE OF [124I]-IODOBENZOYL (IB) PF 06687234 WITH CONCURRENT ADMINISTRATION OF NON-RADIOLABELED PF 06687234 AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) IMAGING IN MODERATE TO SEVERE ULCERATIVE COLITIS SUBJECTS
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  12/31/1969
American Research Corporation at Texas Liver Institute
mi
from
San Antonio, TX
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 12/31/1969
American Research Corporation at Texas Liver Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  12/31/1969
APEX GmBH
mi
from
Munich,
Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function
A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 12/31/1969
APEX GmBH
mi
from
Munich,
Click here to add this to my saved trials
First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Novel Oral Peptide BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
Celerion
mi
from
Lincoln, NE
First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Novel Oral Peptide BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Obesity, Iron Regulation and Colorectal Cancer Risk
Obesity, Iron Regulation and Colorectal Cancer Risk
Status: Enrolling
Updated:  12/31/1969
University of Illinois at Chicago
mi
from
Chicago, IL
Obesity, Iron Regulation and Colorectal Cancer Risk
Obesity, Iron Regulation and Colorectal Cancer Risk
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Status: Enrolling
Updated:  12/31/1969
Cancer Therapy and Research Center at UTHSCSA
mi
from
San Antonio, TX
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis
Status: Enrolling
Updated: 12/31/1969
Cancer Therapy and Research Center at UTHSCSA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.
A Pilot Study Evaluating the Synergistic Effect of Vedolizumab in Conjunction With Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis.
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.
A Pilot Study Evaluating the Synergistic Effect of Vedolizumab in Conjunction With Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis.
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Transfusions and Nitric Oxide Level in Preterm Infants
Transfusions and Nitric Oxide Level in Preterm Infants
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Transfusions and Nitric Oxide Level in Preterm Infants
Transfusions and Nitric Oxide Level in Preterm Infants
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
A Randomized Trial Comparing Once Daily Dosing vs. Multiple Doses a Day of Mesalamine in Pediatric Patients With Quiescent Ulcerative Colitis
Status: Enrolling
Updated:  12/31/1969
Morristown Memorial Hospital/Goyerb Children's Hospital
mi
from
Morristown, NJ
Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
A Randomized Trial Comparing Once Daily Dosing vs. Multiple Doses a Day of Mesalamine in Pediatric Patients With Quiescent Ulcerative Colitis
Status: Enrolling
Updated: 12/31/1969
Morristown Memorial Hospital/Goyerb Children's Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
A Randomized, Placebo-Controlled, Sequential Single and Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
Status: Enrolling
Updated:  12/31/1969
Landos Biopharma Inc.
mi
from
Blacksburg, VA
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
A Randomized, Placebo-Controlled, Sequential Single and Multiple Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
Status: Enrolling
Updated: 12/31/1969
Landos Biopharma Inc.
mi
from
Blacksburg, VA
Click here to add this to my saved trials
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Status: Enrolling
Updated:  10/7/2008
Children's Hospital - Boston
mi
from
Boston, MA
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Status: Enrolling
Updated: 10/7/2008
Children's Hospital - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Status: Enrolling
Updated:  10/7/2008
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
Status: Enrolling
Updated: 10/7/2008
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Vitamin D Levels in Children With IBD
Optimization of Vitamin D Stores and Its Impact on the Bone Health and Disease Outcomes of Children and Adolescents With IBD.
Status: Enrolling
Updated:  1/27/2009
Children's Hospital Boston
mi
from
Boston, MA
Vitamin D Levels in Children With IBD
Optimization of Vitamin D Stores and Its Impact on the Bone Health and Disease Outcomes of Children and Adolescents With IBD.
Status: Enrolling
Updated: 1/27/2009
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Effectiveness of Cognitive Behavioral Therapy in Reducing Depressive Symptoms in Physically Ill Youth
Reducing Depressive Symptoms in Physically Ill Youth
Status: Enrolling
Updated:  4/27/2009
Children's Hospital - Boston
mi
from
Boston, MA
Effectiveness of Cognitive Behavioral Therapy in Reducing Depressive Symptoms in Physically Ill Youth
Reducing Depressive Symptoms in Physically Ill Youth
Status: Enrolling
Updated: 4/27/2009
Children's Hospital - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Effectiveness of Cognitive Behavioral Therapy in Reducing Depressive Symptoms in Physically Ill Youth
Reducing Depressive Symptoms in Physically Ill Youth
Status: Enrolling
Updated:  4/27/2009
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Effectiveness of Cognitive Behavioral Therapy in Reducing Depressive Symptoms in Physically Ill Youth
Reducing Depressive Symptoms in Physically Ill Youth
Status: Enrolling
Updated: 4/27/2009
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Melatonin & Ulcerative Colitis
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Status: Enrolling
Updated:  12/22/2009
Emory University
mi
from
Atlanta, GA
Melatonin & Ulcerative Colitis
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Status: Enrolling
Updated: 12/22/2009
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Melatonin & Ulcerative Colitis
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Status: Enrolling
Updated:  12/22/2009
Consultative Gastroenterology
mi
from
Atlanta, GA
Melatonin & Ulcerative Colitis
Melatonin and Ulcerative Colitis: A Pilot Clinical Trial
Status: Enrolling
Updated: 12/22/2009
Consultative Gastroenterology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #059
mi
from
Birmingham, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #059
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #042
mi
from
Huntsville, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #042
mi
from
Huntsville, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #033
mi
from
Montgomery, AL
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #033
mi
from
Montgomery, AL
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #067
mi
from
Scottsdale, AZ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #067
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #090
mi
from
Tucson, AZ
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #090
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #068
mi
from
Jonesboro, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #068
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 10
mi
from
Little Rock, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 10
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #093
mi
from
Lowell, AR
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #093
mi
from
Lowell, AR
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site 062
mi
from
Fresno, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site 062
mi
from
Fresno, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #057
mi
from
Madera, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #057
mi
from
Madera, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #060
mi
from
Palm Springs, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #060
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #095
mi
from
Roseville, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #095
mi
from
Roseville, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #003
mi
from
San Carlos, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #003
mi
from
San Carlos, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #022
mi
from
San Diego, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #022
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #052
mi
from
Santa Monica, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #052
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Investigational Site #086
mi
from
West Covina, CA
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Investigational Site #086
mi
from
West Covina, CA
Click here to add this to my saved trials
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  9/27/2010
Prometheus Site 27
mi
from
Lafayette, CO
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of COLAL-PRED in the Treatment of Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 9/27/2010
Prometheus Site 27
mi
from
Lafayette, CO
Click here to add this to my saved trials